WallStreetZenWallStreetZen

NYSEMKT: PTHS
Pelthos Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for PTHS

Based on 1 analyst offering 12 month price targets for Pelthos Therapeutics Inc

Min Forecast
$50.00+76.99%
Avg Forecast
$50.00+76.99%
Max Forecast
$50.00+76.99%

Should I buy or sell PTHS stock?

Based on 1 analyst offering ratings for Pelthos Therapeutics Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although PTHS's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates PTHS as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their PTHS stock forecasts and price targets.

PTHS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-09-02

1 of 1

Forecast return on equity

Is PTHS forecast to generate an efficient return?

Company
-93.22%
Industry
106.56%
Market
-57.53%
PTHS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PTHS forecast to generate an efficient return on assets?

Company
735.72%
Industry
46.71%
PTHS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PTHS earnings per share forecast

What is PTHS's earnings per share in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$5.48
Avg 2 year Forecast
-$2.40
Avg 3 year Forecast
-$0.11

PTHS revenue forecast

What is PTHS's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$11.8M
Avg 2 year Forecast
$36.6M
Avg 3 year Forecast
$77.8M

PTHS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PTHS$28.25$50.00+76.99%Buy
COEP$17.68N/AN/A
HYFT$1.83$5.00+173.22%Buy
ENTX$1.84N/AN/A
PSTV$0.89$8.00+798.88%Strong Buy
View Top Biotech Stocks

Pelthos Therapeutics Stock Forecast FAQ

Is Pelthos Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSEMKT: PTHS) stock is to Buy PTHS stock.

Out of 1 analyst, 0 (0%) are recommending PTHS as a Strong Buy, 1 (100%) are recommending PTHS as a Buy, 0 (0%) are recommending PTHS as a Hold, 0 (0%) are recommending PTHS as a Sell, and 0 (0%) are recommending PTHS as a Strong Sell.

If you're new to stock investing, here's how to buy Pelthos Therapeutics stock.

What is PTHS's earnings growth forecast for 2025-2027?

(NYSEMKT: PTHS) Pelthos Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.08%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.52%.

Pelthos Therapeutics's earnings in 2025 is -$9,037,939.On average, 1 Wall Street analyst forecast PTHS's earnings for 2025 to be -$16,670,944, with the lowest PTHS earnings forecast at -$16,670,944, and the highest PTHS earnings forecast at -$16,670,944. On average, 1 Wall Street analyst forecast PTHS's earnings for 2026 to be -$7,301,143, with the lowest PTHS earnings forecast at -$7,301,143, and the highest PTHS earnings forecast at -$7,301,143.

In 2027, PTHS is forecast to generate -$334,636 in earnings, with the lowest earnings forecast at -$334,636 and the highest earnings forecast at -$334,636.

What is PTHS's revenue growth forecast for 2025-2027?

(NYSEMKT: PTHS) Pelthos Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 85.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.51%.

Pelthos Therapeutics's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast PTHS's revenue for 2025 to be $35,806,023, with the lowest PTHS revenue forecast at $35,806,023, and the highest PTHS revenue forecast at $35,806,023. On average, 1 Wall Street analysts forecast PTHS's revenue for 2026 to be $111,342,434, with the lowest PTHS revenue forecast at $111,342,434, and the highest PTHS revenue forecast at $111,342,434.

In 2027, PTHS is forecast to generate $236,709,147 in revenue, with the lowest revenue forecast at $236,709,147 and the highest revenue forecast at $236,709,147.

What is PTHS's forecast return on assets (ROA) for 2025-2028?

(NYSEMKT: PTHS) forecast ROA is 735.72%, which is higher than the forecast US Biotechnology industry average of 46.71%.

What is PTHS's Price Target?

According to 1 Wall Street analyst that have issued a 1 year PTHS price target, the average PTHS price target is $50.00, with the highest PTHS stock price forecast at $50.00 and the lowest PTHS stock price forecast at $50.00.

The Wall Street analyst predicted that Pelthos Therapeutics's share price could reach $50.00 by Sep 2, 2026. The average Pelthos Therapeutics stock price prediction forecasts a potential upside of 76.99% from the current PTHS share price of $28.25.

What is PTHS's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSEMKT: PTHS) Pelthos Therapeutics's current Earnings Per Share (EPS) is -$14.68. On average, analysts forecast that PTHS's EPS will be -$5.48 for 2025, with the lowest EPS forecast at -$5.48, and the highest EPS forecast at -$5.48. On average, analysts forecast that PTHS's EPS will be -$2.40 for 2026, with the lowest EPS forecast at -$2.40, and the highest EPS forecast at -$2.40. In 2027, PTHS's EPS is forecast to hit -$0.11 (min: -$0.11, max: -$0.11).

What is PTHS's forecast return on equity (ROE) for 2025-2028?

(NYSEMKT: PTHS) forecast ROE is -93.22%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.